Clinical trials · Detroit, MI
Acute Myeloid Leukemia Post Cytotoxic Therapy clinical trials in Detroit
We’re tracking 5 recruiting acute myeloid leukemia post cytotoxic therapy studies with a site in or near Detroit — including Phase 1, Phase 1/Phase 2, Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Detroit
- NCT05554406RecruitingPhase 2
New drug therapy for high-risk AML
This trial is testing new drug combinations for people with newly diagnosed, high-risk AML who have not yet started treatment. It aims to find more effective therapies for this aggressive form of leukemia.
Detroit, MichiganAges 18–59 - NCT05564390RecruitingPhase 2
MyeloMATCH screening to match you to AML or MDS treatment
This study screens people with newly suspected acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) to see which treatment approach fits best—either a specific study treatment or standard care. It may help by directing you to the right option and by sharing your blood/bone marrow samples for research.
Detroit, MichiganAges 18 years+ - NCT05183035RecruitingPhase 3
Testing venetoclax for children with relapsed AML
This study tests a drug called venetoclax in children and young adults whose acute myeloid leukemia (AML) has returned after treatment. The drug may help block cancer cell growth. The study also looks at safety and how well the drug works when given alone or with other treatments.
Detroit, MichiganAges 4 weeks–21 years - NCT04726241RecruitingPhase 1/Phase 2
Testing blood and bone marrow samples in young leukemia patients
This trial looks at blood and bone marrow samples from children and teens whose leukemia has come back or is hard to treat. The goal is to better understand the disease and guide future options for these patients.
Detroit, MichiganAges Up to 22 years - NCT07012044RecruitingPhase 1
Cedazuridine and decitabine after stem cell transplant for childhood leukemia
This trial tests if adding two chemotherapy drugs (cedazuridine and decitabine) along with a growth factor (filgrastim) can help prevent leukemia from coming back after a stem cell transplant. It is for children and young adults with high-risk acute myeloid leukemia who are in remission after transplant.
Ann Arbor, MichiganAges Up to 21 years
Hear when a new Acute Myeloid Leukemia Post Cytotoxic Therapy trial opens near Detroit, MI
We’ll email you when one opens near Detroit, MI — at most once a week, no account needed, unsubscribe anytime.
Acute Myeloid Leukemia Post Cytotoxic Therapy trials in other cities
Where these studies are running near Detroit
Institutions with a site for the recruiting acute myeloid leukemia post cytotoxic therapy studies listed above.
- University of Michigan · 3 studies
- Children's Hospital of Michigan · 2 studies
- Henry Ford Health · 2 studies
- Henry Ford Macomb Hospital-Clinton Township · 2 studies
- Henry Ford Medical Center-Columbus · 2 studies
- Henry Ford West Bloomfield Hospital · 2 studies
- Trinity Health IHA Medical Group Hematology Oncology - Brighton · 2 studies
- Trinity Health IHA Medical Group Hematology Oncology - Canton · 2 studies
What taking part in a acute myeloid leukemia post cytotoxic therapy study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting acute myeloid leukemia post cytotoxic therapy studies in Michigan.
Common questions
- Are there acute myeloid leukemia post cytotoxic therapy clinical trials near Detroit?
- Yes. We're currently tracking 5 recruiting acute myeloid leukemia post cytotoxic therapy studies with a site near Detroit, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a acute myeloid leukemia post cytotoxic therapy study near Detroit?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Detroit to take part?
- Not necessarily. These studies have a site near Detroit, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a acute myeloid leukemia post cytotoxic therapy trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New acute myeloid leukemia post cytotoxic therapy studies open near Detroit regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.